Disclosed herein are methods for the reduction of inter-patient variability of a drug, such as in one or more parameters including half-life (t.sub.1/2), maximum plasma concentration (C.sub.max), time at maximal plasma concentration (T.sub.max), area under the time-versus-concentration curve (AUC). Also provided are methods of reducing side effects associated with drugs.